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Available online 18 May 2012Abstract It has been verified that placenta contains multi-lineage mesenchymal stem cells (MSCs). We have used a
time-gradient attachment method to isolate placenta-derived MSCs (PMSCs). The morphology, differentiation potential,
immunogenicity and xenogenic reconstruction potential of these PMSCs were examined. The results showed that PMSCs
isolated using the time-gradient attachment method showed higher potential of in vitro proliferation and multi-lineage
differentiation. PMSCs isolated using the time-gradient attachment method showed a low immunogenicity. HLA-A gene
fragment and no HLA-DR gene fragment were detected in PMSCs isolated using the time-gradient attachment method, and the
mixed lymphocyte reaction (MLR) assay identified that these cells inhibited the proliferation of the allogeneic T-lymphocytes
induced by PHA. The transplantation in calvaria of rats showed that PMSCs had the higher xenogenic reconstruction potential.
Finally, the significance of PMSCs isolated using the time-gradient attachment method in experimental and clinical applications
is discussed.
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Mesenchymal stem cells (MSCs) represent a multi-potential
adult cellular population. In addition to their potentials of
maintenance and regeneration to multiple tissues (Pittenger et
al., 1999), MSCs are not only unable to elicit allogeneic T-cell
responses (Rasmusson et al., 2003) but also able to suppress
T-cell proliferation in mixed lymphocyte reaction (MLR) (Di
Nicola et al., 2002; Krampera et al., 2003; Le Blanc et al., 2003;
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property, MSCs have been used for the effective treatment of
graft-versus-host disease (GVHD) (Le Blanc et al., 2004).
Human mesenchymal stem cells (hMSCs) are isolated firstly
from bone marrow (BM) (Friedenstein et al., 1976; Caplan,
1991) and isolated subsequently from other tissues such as
adipose tissue, umbilical cord cutaneous tissue, fetal liver and
pulmonary tissue (Rodriguez et al., 2005; Romanov et al., 2003;
Campagnoli et al., 2001). Placental tissue originates during the
first stages of embryological development. It is possible that
this tissue may contain some cells with the plasticity of the
early embryonic cells. Meanwhile, placental tissue is funda-
mental for maintaining fetomaternal tolerance during pregnan-
cy. It implies that some cells in placental tissue should have
immunomodulatory characteristics. These key points make
some cells fromplacenta as good candidates in the cell therapy.
In addition, placenta is abundantly available and can provide an
ethically uncontroversial and easily accessible source of cells
for experimental and clinical application (Zhang et al., 2004).
Previous studies showed that multi-lineage mesenchymal stem
cells could be isolated from human term placenta using the
direct attachment method (Fukuchi et al., 2004; Igura et al.,
2004; Miao et al., 2006). Adipogenic and osteogenic differen-
tiation of placenta-derived MSCs have been achieved under the
appropriate conditions (Yen et al., 2005). In addition, hMSCs
from placental tissue have been recently prospectively identi-
fied and purified as vascular pericytes (Crisan et al., 2008).
However, the attachable cells isolated using the direct
attachment methods in our lab consisted usually of MSC-like
cells and other fibroblast-like cells. Three kinds of principal cell
types, defined as amniotic epithelial cells (AEC), amniotic
mesenchymal stromal cells (AMSC) and chorionic trophoblastic
cells (CTC), can be isolated from the fetal membranes of term
placenta, and all of these cells have the adhesion property
(Parolini et al., 2008). Therefore, it is necessary to use an
efficient technique to isolate placenta-derived mesenchymal
stem cells (PMSCs). This technique should be effective enough
to get rid of other fibroblast-like cells. In recent years, a
preplate culture method was used to isolate MSC-like cells from
solid tissues such as skeletal muscle (Gharaibeh et al., 2008;
Clause et al., 2010; Ji et al., 2010; Sharifiaghdas et al., 2011).
This technique is used to select cells after serial adherences,
based on their special adherence ability to plastic. In the
present study, we modified the preplate culture method as the
time-gradient attachment method to isolate PMSCs from
placenta (see Materials and methods). The isolation of PMSCs
from placenta with this method is based on the difference of
adhesion ability between different cells. We analyzed the
biological characteristics of these PMSCs isolated using the
time-gradient attachment method, and transplanted these
cells into the calvarium of rat to repair the calvarial defect.
Finally, the immunomodulatory characteristics and reconstruc-
tion function of PMSCs isolated using the time-gradient
attachment method were discussed.Results
Characterization of placenta-derived MSCs
We used two different methods to isolate cells from placenta
(see Materials and methods). In the direct attachmentmethod, the adherent cells in primary passage consisted of
two cell populations with different morphologies: some cells
exhibited a spindle-shapedmorphology, and others were small
and round or polygonal cells (Fig. 1A). All adherent cells could
proliferate and form a fibroblastoid layer during passage 1
(Fig. 1B). In the time-gradient attachment method, cells
adhered in 24 h (Fig. 1C) and 48 h (Fig. 1D) were difficult to
proliferate due to the low density. However, the morphology
of cells adhered in 72 h changed gradually from spindle-
shaped morphology (Fig. 1E) into fibrous morphology and
finally formed a homogeneous layer of cells during passage 1
(Fig. 1F). These adherent cells could be readily expanded in
vitro by successive cycles of trypsinization, seeding, and
culture for about 10 passages (average 4–5 d for one passage)
with no visible morphologic alteration. Cells isolated using the
direct attachment and the time-gradient attachment for 72 h
were analyzed cell-surface molecules by the flow cytometry.
The phenotype of the cells isolated using the direct attach-
ment was positive for CD29, CD73, CD90, CD105 and CD117,
and negative for CD34 and CD45. The phenotype of the cells
isolated using the time-gradient attachment for 72 h was
positive for CD29, CD73, CD90 and CD105, and negative for CD
34, CD45 and CD117 (Fig. 1G).
Cells isolated using above both attachment methods were
determined by their growth characteristics. Cells at passage 3
were cultured for 8 d and the growth kinetic was analyzed as
in Fig. 2. For the cells isolated using the direct attachment,
the cell density reached its peak at day 6, and cells entered
the logarithmic growth phase at day 4. For the cells isolated
using the time-gradient attachment for 72 h, the cell density
reached its peak at day 7, and cells entered the logarithmic
growth phase at day 5 (Fig. 3A). We calculated that the
doubling time for cells isolated using the direct attachment
was 28.2 h, whereas the doubling time for cells isolated using
the time-gradient attachment for 72 h was 32.6 h. However,
the doubling time for cells isolated using the time-gradient
attachment for 72 h deceased gradually as passaging (Fig. 2B).
The result suggested that the proliferation rate of cells
isolated using the time-gradient attachment for 72 h was
higher than that of cells isolated using the direct attachment.Multi-differentiation of placenta-derived MSCs
Induction of osteogenesis, adipogenesis and chondrogenesis
was performed for cells isolated using above both attachment
methods to analyze their multi-potentials of differentiation.
Under induction with osteogenic medium for 14 days, the cells
isolated using the time-gradient attachment for 72 h were
induced to osteoblast-like cells and showed the positive
staining of ALP and calcium deposits (Figs. 3A1 and A3). The
cells isolated using the direct attachment also showed positive
reaction under induction of osteogenic condition for 14 days
(Figs. 3A2 and A4). However, the ALP activity analysis showed
that the osteogenic potential of cells isolated using the time-
gradient attachment for 72 h was significantly higher than
that of cells isolated using the direct attachment (Fig. 3B)
(Pb0.05). The ALP activity level of cells isolated using the
time-gradient attachment for 72 h increased gradually under
induction and reached the highest level (2.18 μg/2×104 cells)
at day 10. The expression levels of osteoblast-specific genes
ALP and Runx2 in cells isolated using the time-gradient
Figure 1 Morphological and phenotypical characteristics of cells isolated from placenta using both attachment methods (×100).
(A) Cells isolated using the direct attachment method in passage 0. (B) Cells isolated using the direct attachment method in passage
3. (C) Cells isolated using the time-gradient attachment for 24 h. (D) Cells isolated using the time-gradient attachment for 48 h.
(E) Cells isolated using the time-gradient attachment for 72 h in passage 0. (F) Cells isolated using the time-gradient attchment
method for 72 h in passage 3 (black arrows show the small and round or polygonal cells, and white arrows show the spindle-shaped
cells). Scale bars: 200 μm. (G) Flow cytometric analysis of surface antigen expression of the cells isolated using both attachment
methods (TM: cells isolated using the time-gradient attachment for 72 h, DM: cells isolated using the direct attachment).
Figure 2 Growth characteristic of cells isolated using both
attachment methods. (A) Growth curve of cells isolated using
both attachment methods. (B) Doubling time of cell populations
isolated using both attachment methods. All the experiments
were conducted independently (n=3). Error bars represent SD
(Pb0.05). TM: cells isolated using the time-gradient attachment
for 72 h, DM: cells isolated using the direct attachment.
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isolated using the direct attachment (Pb0.05) (Fig. 3C). The
alcian blue 8GX staining and EnVision two-step immunohisto-
chemical staining were used to detect chondrocyte-specific
cartilage proteoglycans and type II collagen (COL II). Although
Figs. 3A5–3A8 showed the positive staining of cartilage
proteoglycans and type II collagen in both cells isolated using
the time-gradient attachment for 72 h and the direct
attachment, the expression level of chondroitin sulfate
proteoglycan 4 (CSPG4) and COL II genes was significantly
different between both cells isolated using the time-gradient
attachment for 72 h and the direct attachment (Pb0.05)
(Fig. 3C). In addition, the adipogenesis of cells isolated using
both attachment methods was apparent under induction
with the adipogenic medium for 2 days. The lipid vacuoles
continued to develop into coalesced and eventually filled the
cell. The accumulation of intracellular lipid droplets was
visualized by staining with Oil Red O at day 14 as Figs. 3A9 and
3A10. However, the percentage of cells that contained lipid
droplets in both cells isolated using the time-gradient
attachment for 72 h and the direct attachment was signifi-
cantly different. It was 67.24±3.93% of total cell number
for cells isolated using the time-gradient attachment for 72 h,
and 32.46±7.93% of total cell number for cells isolated using
the direct attachment (Pb0.05). The expression levels of
adipocyte-specific genes adipsin, PPARγ and leptin in cells
isolated using the time-gradient attachment for 72 hwere also
higher than those of cells isolated using the direct attachment
Figure 3 Multi-differentiation potentials of cells isolated using both attachment methods. (A) The modified Gomori calcium–cobalt
staining for ALP (A1 for TM, A2 for DM), the Alizarin red staining for calcium deposits (A3 for TM, A4 for DM), the alcian blue 8GX
staining for cartilage proteoglycan (A5 for TM, A6 for DM), the EnVision two-step immunohistochemical staining for type II collagen
(A7 for TM, A8 for DM), and the Oil Red O staining for lipid droplets (A9 for TM, A10 for DM). Scale bars: 200 μm for A1–A4 and A9–A10,
100 μm for A5–A8. (B) Analysis of ALP activity level. (D) Expression of osteogenic genes ALP and Runx2, adipogenic genes adipsin,
PPARγ and leptin, chondrogenic genes COL II and CSPG4 in cells isolated using both attachment method. Lane 1: induced cells isolated
using the time-gradient attachment, Lane 2: induced cells isolated using the direct attachment, Lane 3: un-induced cells isolated
using the time-gradient attachment, and Lane 4: un-induced cells isolated using the direct attachment. TM: cells isolated using time-
gradient attachment method, DM: cells isolated using the direct attachment method. A statistically significant difference was shown
as *Pb0.05 and **Pb0.01 (n=3) between both cells isolated using the time-gradient attachment and the direct attachment.
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114 W. Yuan et al.(Pb0.05) (Fig. 3C). Un-induced cells isolated using above both
attachment methods showed negative for all staining (no data
shown) and for expression of all specific genes (Fig. 3C).
Analysis of immunogenicity and immunomodulation
Flow cytometric analysis was used to detect the expression
patterns of HLA-I and HLA-II in cells isolated using above
both attachment methods. Cells were probed with mono-
clonal antibodies specific for HLA-ABC and HLA-DR. The
results showed that HLA-DR was only expressed in cells
isolated using the direct attachment method though HLA-
ABC expression was highly fluorescent on the surface of cells
isolated using both methods (Fig. 4A). It revealed that cells
isolated using the direct attachment method should be
positive for HLA type I marker HLA-A and HLA type II marker
HLA-DR. No positivity of HLA type II marker HLA-DR was
detected in cells isolated using the time-gradient attach-
ment for 72 h. Furthermore, the gene expression of HLA-ABC
and HLA-DR also confirmed the results of flow cytometry
(Fig. 4B). Cells isolated using the direct attachment method,
as PBLs used as the positive control, expressed both genes.
MLR study was used to investigate the immunological
properties and the suitability of cells for allogeneic transplan-
tation. To determine whether cells isolated using above both
attachment methods suppress alloreactive T-lymphocytes,
cells were co-cultured with T-lymphocytes from allogeneic
human peripheral blood. Results showed the proliferation of
the T-lymphocytes induced by PHA could be decreased when
co-cultured with cells isolated using time-gradient attach-
ment for 72 h (Fig. 4C). On the contrary, the proliferation of
the T-lymphocytes induced using PHAwas promoted by the co-
culture with cells isolated using the direct attachment
method. Cells isolated using the time-gradient attachment
for 72 h resulted in 55.87% proliferation inhibition of alloge-
neic T-lymphocyte, and cells isolated using the direct
attachment method resulted in 36.02% proliferation promo-
tion of allogeneic T-lymphocyte.
Repairing function of placenta-derived MSCs on
calvarial defects of rat
PLGA-cell constructs were prepared as described in
Materials and methods. Calvarial defects (5 mm in diame-
ters, full-thickness) of rat were generated and then
transplanted with PLGA-cell construct in the same size as
the calvarial defect. In addition, the calvarial defect grafted
by no any graft or by the blank scaffold was used as negative
controls. The animals grafted by constructs with cells
labeled by fluorescent carbocyanine CM-Dil were sacrificed
at 10 weeks after transplantation and cells in the graft area
were traced as in Fig. 5. Under fluorescein microscopy, we
detected numerous labeled human cells in the area grafted
by the construct with cells isolated using the time-gradient
attachment for 72 h or the direct attachment (Figs. 5C and
5D, red staining). However, there were no human cells in the
area grafted by no any graft or by the blank scaffold (Fig. 5A
and 5B). By visual inspection, the distribution of human cells
in the area grafted by the construct with cells isolated using
the time-gradient attachment for 72 h seemed to be more
abundant than that in the area grafted by the construct withcells isolated using the direct attachment. Counterstaining
with DAPI showed that the space without human cells was
filled with native cells of rat (blue staining).
Other animals were sacrificed at 20 weeks after transplan-
tation and the whole calvaria were harvested for macroscopic
examination. Figs. 6A1–6A3 showed that the bone-like tissue
filled in the areas grafted by both PLGA-cell constructs.
However, the bone-like tissue in the area grafted by the
construct with cells isolated using the time-gradient attach-
ment for 72 h (the left areas in Figs. 6A1 and 6A2) (1.14±
0.17 mm)was thicker than the tissue in the area grafted by the
construct with cells isolated using the direct attachment (the
right area in Fig. 6A1 and the left area in Fig. 6A3) (0.85±
0.12 mm) (Pb0.05). Only a thin membrane in the defect area
without any graft (the right area in Fig. 6A4) and a fibrous-like
connective tissue in the defect area grafted by the blank
scaffold (the right areas in Figs. 6A2–A3 and the left area in
Fig. 6A4) were observed. The bone reconstruction percentage
analysis was performed by Image-Pro Plus. Fig. 6F indicated
that the new bone formation rate in the areas grafted by the
construct with cells isolated using the time-gradient attach-
ment for 72 h (57.3±7.1%) and the direct attachment (32.5±
3.9%), which were higher than those in the area grafted by the
blank scaffold (12.7±3.3%) and without any graft (1.9±0.8%)
(Pb0.01). In addition, there was also a significant difference
of new bone formation percentage between areas grafted by
both constructs with cells isolated using the time-gradient
attachment for 72 h and the direct attachment (Pb0.05).
The reconstruction process of bone in the calvarial defect
was evaluated by histological analysis. At 20 weeks after
transplantation, few of residual scaffold material were
detected in all defect areas (Figs. 6B1–B4). The obvious
small lump bone was formed in the graft areas grafted by both
constructs with cells isolated using the time-gradient attach-
ment for 72 h and the direct attachment, especially in the
area grafted by the construct with cells isolated using the
time-gradient attachment for 72 h (Fig. 6B3). In addition,
collagen, a major extracellular matrix, was produced in the
newly formed tissues, as determined by Masson's Trichrome
staining (Figs. 6D2–D4). In comparison of two areas grafted
respectively by both constructs, however, the area grafted by
the construct with cells isolated using the direct attachment
appeared to show some inflammatory cells around the small
lump bone (white arrow shown in Fig. 6B4). The inflammatory
response was further monitored by examining CD11b+
expression. Figs. 6C1–C3 showed that the areas grafted by
the construct with cells isolated using the time-gradient
attachment for 72 h, the blank scaffold and no any graft had
few of CD11b+ cells while the area grafted by the construct
with cells isolated using the direct attachment had a higher
inflammatory response (Fig. 6C4). Therefore, it was inferred
that a slight inflammatory reaction should be produced in the
area grafted by the construct with cells isolated using the
direct attachment method.
The immunohistochemical analysis specific to human
cells was performed to evaluate the survival and function
of both cells isolated using the time-gradient attachment for
72 h and the direct attachment in the xenogenic transplan-
tation. The areas grafted by both constructs with cells
isolated using both attachment methods showed the positive
staining of human osteocalcin (Figs. 6E3 and E4). However,
in comparison of staining images for human osteocalcin
Figure 4 Analysis on immunogenicity and immunomodulation of cells isolated using both attathment methods. (A) Phenotype profiles
of cells isolated using both attachment methods. Cells stained with fluorochrome-conjugated antibodies against HLA-ABC, and HLA-DR
respectively. (B) Expression analysis of HLA-ABC and HLA-DR genes in cells isolated using both attachment method and PBLs. (C) T cells
proliferative response to cells isolated using both attachment method. TM: cells isolated using time-gradient attachment method, DM:
cells isolated using direct attachmentmethod, T+P: T lymphocytes induced by PHA, TM+T+P: T lymphocytes induced by PHA co-cultured
with cells isolated using the time-gradient attachment method, DM+T+P: T lymphocytes induced by PHA co-cultured with cells isolated
using the direct attachment method, TM+T: T lymphocytes co-cultured with cells isolated using the time-gradient attachment method,
DM+T: T lymphocytes co-cultured with cells isolated using the direct attachment method, TM+P: cells isolated using the time-gradient
attachment method induced by PHA, DM+P: cells isolated using the direct attachment method induced by PHA, and T: T lymphocytes
alone. Cells were cultured for 72 h, and then treated with MTT for 4 h. The fluorescence was read using a wavelength of 490 nm. All the
experiments were conducted independently (n=3). Error bars represent SD (Pb0.05).
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image against human OCN (5.43±1.52) in the area grafted by
construct with cells isolated using the time-gradient attach-
ment for 72 h was higher than that (4.22±0.86) in the areagrafted by the construct with cells isolated using the direct
attachment (Pb0.05), which suggested that the level of
human osteocalcin in the area grafted by the former
construct was higher than that in the area grafted by the
Figure 5 Cell tracing in vivo at 10 weeks post-transplantation. Cells in PLGA scaffold were labeled by fluorescent carbocyanine CM-
Dil. (A) is the stained area grafted by no any graft, (B) is the stained area grafted by the blank scaffold, (C) is the stained area grafted
by the construct with cells isolated using the time-gradient attachment for 72 h, and (D) is the staining area grafted by the construct
with cells isolated using the direct attachment. The red staining represents human cells survival in rats after transplantation. The
blue staining show native cells in rats counterstained with DAPI. Scale bars: 250 μm.
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any graft showed the negative staining of human osteocalcin
(Figs. 6E1 and E2).Discussion
The presence of multi-lineage mesenchymal stem cells in
the placenta has tremendous implications. Along with the
multi-differentiation capability, the easy accessibility, the
abundant source and no ethical concerns, placenta-derived
MSCs (PMSCs) may be an attractive, alternative progenitor or
stem cells for basic research and clinical applications
(Winkler et al., 2005). However, the question arises as how
to isolate and purify efficiently PMSCs from placenta. In the
previous research, multi-lineage mesenchymal stem cells
from placenta were isolated generally using the directFigure 6 Repairing effects of constructs with cells isolated usi
(A1–A4) Gross views of rat calvarias at 20 weeks after transplantatio
black arrow: the right defect). (B1–B4) H & E staining images of graf
(C1–C4) Immunofluorescence staining images of CD11b+ cells in the gr
isolated using the direct attachment had a higher inflammatory resp
showed collagen produced in the newly formed tissues (blue staining
osteocalcin (OCN) in the graft areas. From B to E, 1 is for the area witho
the area grafted by the construct with cells isolated using the time-g
construct with cells isolated using the direct attachment, respectively
for D1–D4 and E1–E4. (F) Bone regeneration percentage of the defec
different bone regeneration ability in the area grafted by no any graft (
using the time-gradient attachment (TM) and by the construct with
significant difference was shown as Pb0.01 (n=5) between different gattachment method (Miao et al., 2006; Soncini et al., 2007;
Huang et al., 2009; Dimitrov et al., 2010; Fukuchi et al.,
2004). The direct attachment method used in various reports
was different. Dimitrov et al. (2010) reported that cells
adhered in 24 h could be isolated into PMSCs. However, Miao
et al. (2006) and Fukuchi et al. (2004) found that cells
needed 3–5 d of initiating incubation before the adherent
cells could be cultured into cell colonies. It may imply that
the isolation of multi-lineage mesenchymal stem cells from
placenta tissue should not be simple as the isolation of those
cells from bone marrow. Our results showed that MSC-like
cells in the primary passage from placental tissue should
need a longer time to adhere, and cells isolated using the
time-gradient attachment for 72 h were easier to expand.
Although the direct attachment method is an easier
technique to isolate MSCs from various tissues, the cell
population isolated from placenta using this method in ourng both attachment methods on the calvarial defects of rat.
n relative to A–D groups in Table 1 (white arrow: the left defect,
t areas (white arrow for identification of inflammatory reaction).
aft areas showed that the area grafted by the construct with cells
onse in comparison. (D1–D4) Masson's Trichrome staining images
). (E1–E4) Images of immunohistochemistry assay showed human
ut any graft, 2 is for the area grafted by the blank scaffold, 3 is for
radient attachment for 72 h, and 4 is for the area grafted by the
. Scale bar: 5 mm for A1–A4, 600 μm for B1–B4 and C1–C4, 100 μm
t area at 20 weeks after transplantation. Four bars represent the
BC), by the blank scaffold (BS), by the construct with cells isolated
cells isolated using the direct attachment (DM). A statistically
raft areas.
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fibroblast-like cells. Therefore, it is necessary to use a
technique effective enough to purify MSC-like cells and get
rid of other fibroblast-like cells. In order to solve this key
problem, the step-by-step isolated method was developed
(Miki et al., 2007; Takashima et al., 2004; Wei et al., 2003;
Portmann-Lanz et al., 2006; Wolbank et al., 2007; Bailo et
al., 2004; Ilancheran et al., 2007). Mechanical peeling of
amnion membrane from the underlying chorion was followedby digestion with dispase II and then trypsin–EDTA. In this
isolation system, cells in tissue undergo a long-term of
digestion, which may damage cells. As a source of MSC-like
cells, the placenta also contains some cells with the
adherent characteristics similar to MSCs, such as vascular
endothelial cells or fibroblast cells (Miki et al., 2005;
Richards et al., 1995; Markoff et al., 1983; Terada et al.,
2000; Bilic et al., 2004). However, the ability of adhesion
between different cells from placenta was various. A
118 W. Yuan et al.preplate culture method has been developed to isolate MSC-
like cells form muscle (Gharaibeh et al., 2008; Clause et al.,
2010; Ji et al., 2010; Sharifiaghdas et al., 2011). This
technique is used to select cells after serial adherences,
based on their special adherence ability to plastic. We
modified this method as the time-gradient attachment
method (see Materials and methods) to isolate and expand
PMSCs from human term placentas. We digested cells from
the decidua basalis that contained abundant MSC-like cells
(In't Anker et al., 2004) and isolated PMSCs using the direct
attachment and the time-gradient attachment. The results
showed that cells isolated using both attachment methods
could be expanded in vitro. These cells were fibrous
morphology and the proliferation potential remained after
enzymatic digestion and passaging. However, cells isolated
using the time-gradient attachment for 72 h had the higher
proliferation potential in comparison with cells isolated
using the direct attachment, especially in the later pas-
sages. Meanwhile, the phenotype profile of cells isolated
using the direct attachment was positive for CD29, CD73,
CD90, CD105 and CD117, and negative for CD34 and CD45.
The phenotype profile of cells isolated using the time-
gradient attachment for 72 h was positive for CD29, CD73,
CD90 and CD105, and negative for CD 34, CD45 and CD117. It
is a generally consensus that MSC-like cells are negative for
CD34, CD45 and CD117 (Baksh et al., 2003). CD117, a c-kit
proto-oncogene product was observed both in the spindle
cell and epithelioid subtypes (Sarlomo-Rikala et al., 1998).
Therefore, it could be concluded that cells isolated from
placenta were a complex population that consisted of
various cells with different adhesion abilities and that cells
isolated using the direct attachment might contain other
cells, such as epithelioid cells. In addition, the analysis of
multi-differentiation potentials confirmed that cells isolated
using the time-gradient attachment for 72 h should have the
higher multi-differentiation potentials. Therefore, our re-
sults proved that the cells isolated using the time-gradient
attachment method should be MSC-like cells. It suggested
that the time-gradient attachment method could be a more
practicable and reproducible method for isolation of PMSCs
from placenta. The most significant concern is that although
cells derived using the direct attachment method here had
also characteristics as bona fide MSC cells that had
previously derived using a similar method (Huang et al.,
2009; Dimitrov et al., 2010; Fukuchi et al., 2004), cells
isolated using the time-gradient attachment for 72 h should
contain more PMSCs than cells isolated using the direct
attachment in this study.
MSCs have been shown to have low immunogenicity and to
modulate immunological responses via T-cell suppression
(Rondelli et al., 1996; Haynesworth et al., 1992). We assessed
the immunogenicity of placenta-derived cells isolated using
both attachment methods through analysis of immunological-
relevant cell surface molecules. The analysis of gene expres-
sion by RT-PCR method showed HLA-ABC and HLA-DR gene
fragments detected in the cells isolated using the direct
attachment method. However, no HLA-DR gene fragment was
detected in the cells isolated using the time-gradient
attachment for 72 h. Analysis of flow cytometry confirmed
that cells isolated using the time-gradient attachment for 72 h
do not express HLA-DR but HLA-ABC. The one-way MLR assay
was performed to evaluate the ability of immunomodulation.The results showed that cells isolated using time-gradient
attachment for 72 h could inhibit the proliferation of the
T-lymphocytes, but the cells isolated using the direct
attachment promoted a proliferative response of T lympho-
cytes. Therefore, it indicated that the cells isolated using
time-gradient attachment for 72 h should be a promising
candidate for allogenic transplantation due to their low
immunogenicity and immunomodulation function.
Finally, we seeded both cells isolated using the direct
attachment and the time-gradient attachment for 72 h
respectively into PLGA porous scaffolds and transplanted
both constructs with cells respectively into the calvarial
defects of rat to analyze their xenogenic reconstruction
potentials. At 20 weeks after transplantation, a significant
bone formation was observed in areas grafted by both
constructs with cells isolated using the direct attachment
and the time-gradient attachment for 72 h. The thickness of
new bone formed in the graft area was thinner than that of
rat calvaria surrounding the graft area, but the new bone in
the graft area was relatively compact. As gross view and
histological assay above, the construct with cells isolated
using the time-gradient attachment for 72 h seemed to have
a superior ability of bone reconstruction compared to the
construct with cells isolated using the direct attachment.
According to histological assay, the new bone formation in
the area grafted by the construct with cells isolated using
the time-gradient attachment for 72 h was superior to that
in the area grafted by the construct with cells isolated using
the direct attachment. It was confirmed by the statistical
analysis of bone formation proportion. This inference should
also be confirmed by the immunohistochemistry assay of
human osteocalcin. The positive staining rate of osteocalcin
from human in the area grafted by the construct with cells
isolated using the time-gradient attachment for 72 h was
higher than that in the area grafted by the construct with
cells isolated using the direct attachment.
The immunogenicity of allogenic cells in the recipient is
an important care of clinical cell transplantation. Our results
showed that there is difference of immunogenicity and
special immune modulation between both cells isolated
using the time-gradient attachment for 72 h and the direct
attachment. Nevertheless, Poncelet et al. (2007) found that
xenogenic MSCs with low immunogenicity in vitro elicited an
in vivo immune response after transplantation. In our
experiments, the inflammatory reaction, such as production
of macrophages, was not observed in the area grafted by the
construct with cells isolated using the time-gradient attach-
ment for 72 h. However, this reaction was elicited in the
area grafted by the construct with cells isolated using the
direct attachment. Though our result is not enough to prove
the presentation of a local immune response, it may be an
indication that a local inflammation occurred. The effect of
PLGA scaffold on the inflammatory reaction was excluded
since the same reaction had not been elicited in the area
grafted only PLGA scaffold. Therefore, it is deduced that the
immunogenic characteristics of cells isolated using the time-
gradient attachment for 72 h should be different from those
of cells isolated using the direct attachment, i.e. cells
isolated using the direct attachment might contain some
other types of cells except for PMSCs. However, the in vivo
immunogenicity of PMSCs isolated using the time-gradient
attachment for 72 h as a population of allogeneic cells and
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isolated using the direct attachment should be remained for
further studies.
In summary, PMSCs are isolated from human term
placenta using the time-gradient attachment for 72 h. In
comparison with cells isolated using the direct attachment
method, PMSCs isolated using the time-gradient attachment
for 72 h have the MSC-specific phenotype characteristic, the
multi-differentiation potentials, the immunomodulation
properties, and the higher xenogenic reconstruction poten-
tial. Therefore, the cells isolated using the time-gradient
attachment for 72 h should be promising for experimental
and clinical applications.
Materials and methods
Isolation of placenta-derived cells
Term placentas from healthy donor mothers were obtained
from the Second Hospital of Hangzhou with informed
consent approved by Human Experimentation Committee
at Zhejiang Public Health Bureau. Decidua basalis was
dissected from the central region of the maternal-facing
surface of placenta, washed for three times with phosphate-
buffered saline (PBS), and then mechanically minced,
enzymatically digested with 0.1% collagenase IV for 30 min
at 37 °C and filtered through 400 nylon mesh filter. The cell
suspension was harvested and centrifuged at 2000×g for
10 min. The pellet of cells was resuspended in PBS. Each
10 mL of cell suspension was layered over about 5 mL of
Ficoll and centrifuged at 2500×g for 25 min. Then, the
mononuclear cell layer was collected and suspended in PBS.
Cells were centrifuged at 1500×g for 5 min, and then
repeated this step again. Finally, cells were resuspended in
the complete medium (low-glucose DMEM supplemented
with 10% FBS).
Purification of placenta-derived MSCs
We used two different methods, a direct attachment method
and a time-gradient attachment method, to isolate cells from
placenta. As the direct attachment method, we seeded and
cultured cells in the 24-well plate with the complete medium,
and removed those non-adherent cells by replacing half of
medium after 3–4 d of culture and by replacing whole of
medium after 7 d of culture. After 10 d of culture, the
fibroblast-like cells adhered in the well, as primary passage,
were harvested using 0.25% trypsinase (Gibco-BRL, Hangzhou,
China), and then cells were seeded in the 24-well plate at the
density of 5×104 cells/cm2 and cultured as passage 1. Cells at
passage 3 were used for following analysis. As the time-
gradient attachment method, we seeded and cultured cells in
the 24-well plate with the complete medium for 24 h, and
then harvested and transferred the non-adherent cells into
another 24-well plate for another 48 h of culture. Afterward,
the non-adherent cells were harvested and transferred again
into the third 24-well plate for another 72 h of culture. Finally,
the non-adherent cells after 72 h of culture in the third 24-
well plate were discarded by replacing whole of medium. The
cells attached in these three times (24, 48 and 72 h) were
cultured for 14 d, the fibroblast-like cells adhered in the wellwere harvested using 0.25% trypsinase (Gibco-BRL) and
passaged at the density of 5×104 cells/cm2. Cells at passage
3 were used for following analysis.
In vitro differentiation multi-potentials
To investigate the multi-differentiation potentials of cells
isolated using both attachment methods mentioned above,
cells at passage 3 with 70–80% influence were induced with
osteogenic medium, adipogenic medium and chondrogenic
medium respectively for 14 d. The medium was changed every
3 d. Osteogenic medium was the low-glucose DMEM supple-
mented with 0.1 μM dexamethasone, 50 mM β-glycerol phos-
phate, 0.2 mM ascorbic acid and 10% FBS (Sigma, Shanghai,
China), adipogenic medium was the low-glucose DMEM supple-
mented with 0.25 mM 3-isobutyl-1-methylxanthine, 0.1 μM
dexamethasone, 0.1 mM indomethacin (Sigma), 6.25 μg/mL
insulin (PeproTech, Beijing, China) and 10% FBS (Gibco-BRL),
and chondrogenic medium was high-glucose DMEM containing
transforming growth factor β1 (TGF-β1) (10 ng/mL), IGF-I
(10 ng/mL), vitamin C (VC) (50 μg/mL) and 10% FBS.
For identification of osteogenesis, the modified Gomori
calcium–cobalt method was used to examine intercellular
ALP as described previously with little modification (Zhang
et al., 2004). Briefly, induced cells were fixed with 4%
paraformaldehyde for 10 min, and then rinsed three times
with distilled water. The fixed cells were placed in an
incubation solution that consisted of 5 mL sodium barbital
(20 g/L), 5 mL sodium β-glycerophosphate (30 g/L), 10 mL
calcium chloride (20 g/L), 0.5 mL magnesium sulfate (20 g/L)
(Sinopharm Chemical, Beijing, China) and 2.5 mL distilled
water at 37 °C for 4 h. Afterward, cells were transferred into
cobalt nitrate solution (20 g/L) for 5 min and rinsed with
running water, and then transferred into sulfurated amine
solution (10 g/L) for 5 min and rinsed with running water
again. Finally, stained monolayers were visualized by phase
microscopy using an inverted microscope (Nikon, Shanghai,
China). For ALP activity assay, cells induced respectively for 1,
4, 7, 10 and 14 d were homogenized and incubated in lysis
buffer (0.1% Triton X in PBS) for 30 min in 37 °C. The ALP
activity of supernatant was measured using an ALP measure-
ment kit (Jiancheng Biotechnology Institute, Nanjing, China)
with disodium phenyl phosphate as a substrate. 2.5 μL of
supernatant, 40 μL of buffer and 40 μL of substrate solution
were added into each well of 24-well plate, and followed by
incubation at 37 °C for 15 min. Then, 125 μL of chromogenic
reagent was added to each well. The solution absorption
was read at 520 nm and the ALP activity was expressed as μg
free phenol per 2×104 cells as described previously (Yang
et al., 2010). Samples were in triplicate and compared against
the phenol standards. For mineralization staining, cells were
washed with PBS and fixed in 10% (v/v) formaldehyde (Sigma)
at room temperature for 15 min. Then, cells were washed
twice with distilled water prior to addition of 1 mL of 40 mM
Alizarin red S (ARS) (pH 4.1) per well. The plates were
incubated at room temperature for 20 min with gentle
shaking. After aspiration of the unincorporated dye, the
wells were washed four times with 4 mL distilled water while
shaking for 5 min. Then, the plate was left at an angle for
2 min to facilitate removal of water. Stained cells were
visualized by phase microscopy using an inverted microscope
(Nikon).
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medium, we performed the pellet culture as Johnstone et al.
(1998) with a little modification. Briefly, 2×105 cells were
centrifuged in a 15-mL polypropylene tube, and the pellets
were cultured in chondrogenic induction medium for 14 d.
Then, the pellets were embedded in paraffin, cut into 5 μm
sections and stainedwith alcian blue 8GX to show the cartilage
proteoglycans. The expression of type II collagenwas detected
using EnVision immunohistochemical kit (Dako, Beijing,
China).
To investigate the adipogenic potential of cells isolated
using above both attachment methods, the lipid staining was
performed using the method described by Culling (1963).
Briefly, cells induced with adipogenic medium for 14 d were
washed with PBS and stained with 2.5% Oil Red O dissolved in
distilled water for 15 min at room temperature. Cells were
briefly washed with distilled water at room temperature.
Stained cells were visualized by phase microscopy using an
inverted microscope (Nikon).Mixed lymphocyte reaction (MLR) cultures
Peripheral blood lymphocyte cells (PBLs) were prepared
from human peripheral blood by centrifugation on a Ficoll
density gradient. T-lymphocytes were harvested from PBLs
by using the nylon column as described previously with a
little modification (Sakuragawa et al., 1997). Briefly, nylon
fibers (Fenwal Laboratories, Beijing, China) were firstly
incubated in 0.2 M/L HCl for 6 h and rinsed in distilled water.
Then, a given quantity of nylon fibers was loaded into plastic
syringes to construct a nylon column. Afterward, the nylon
column was rinsed with Earle's saline (ES) containing 10%
heat-inactivated FBS for several times. Before adding
mononuclear cells, the columns were incubated with ES/
10% FBS for 30 min. Then, 2×107 total mononuclear cells
were added in ES containing 10% FBS and run into the
column, and incubated for 30 min at 37 °C. Elution with ES
was run at a speed of 2 mL/min, and the initial 10 mL elution
of cells was collected. The elution was centrifuged at 400×g
for 10 min, and the cells were adjusted to 1×105 cells/mL
for the MLR culture.
The one-way MLR was used to assess T cell reactivity
against allogeneic cell populations. Isolated human T cells
(104 cells/well) or placenta-derived cells (2×103 cells/well)
were cultured in 96-well plates (96 well culture clusters with
low evaporation lids, Corning, Shanghai, China) as following
groups: T-cells plus PHA was set as T+P group, T-cells plus
PHA co-cultured with cells isolated using the time-gradient
attachment for 72 h was set as TM+T+P group, T-cells plus
PHA co-cultured with cells isolated using the direct
attachment was set as DM+T+P group, T-cells co-cultured
with cells isolated using the time-gradient attachment for
72 h was set as TM+T group, T-cells co-cultured with cells
isolated using the direct attachment was set as DM+T group,
cells isolated using the time-gradient attachment for 72 h
plus PHA was set as TM+P group, cells isolated using the
direct attachment plus PHA was set as DM+P group, and
T-cells alone was set as T group. Each group was quadruplet.
T-lymphocytes proliferation was evaluated by MTT and the
cellular proliferation inhibition rate was calculated. Briefly,
cells in the well were placed at 37 °C for 72 h in an incubationsolution. Afterward, cells were treated with MTT (5 mg/mL)
for another 4 h, and then centrifuged at 400×g for 5 min and
discarded the upper layer. Each well was added 150 μL DMSO
and mixed completely. Then, the fluorescence was read on
Auto Microplate Reader (Infinite M200, Tecan, Shanghai,
China) using a wavelength of 490 nm.
RT-PCR analysis of gene expression after induction
Total RNA was extracted from cells with Trizol reagent.
Briefly, 1×105 cells were placed into a 1.5 mL centrifugal tube
followed by adding 1 mL Trizol reagent. Then, chloroform and
isopropanol were used to extract RNA from the lysate. RNA
was washed with 1 mL 75% ethanol and dissolved in the water
treated with diethyl pyrocarbonate (DEPC). The mRNA was
reverse transcribed to cDNA using the Reverse Transcription
System (MBI Fermentas, Wuhan, China) according to the
manufacturer's instructions. Then, we used the cDNA tem-
plate and the designed primers to assay relevant genes
expression by PCR reaction. Briefly, cDNA was amplified
using an PCR system at 94 °C for 40 s, 56 °C for 50 s, and 72 °C
for 60 s for 35 cycles after initial denaturation at 94 °C for
5 min. Primers used for amplification were as follows: GAPDH
5′-GAA GGT CGG AGT CAA CGG-3′, 3′-GGA AGA TGG TGA TGG
GAT T-5′; Runx2: 5′-GTG GAC GAG GCA AGA GTT-3′, 3′-GGT
GCA GAG TTC AGG GAG-5′; ALP: 5′-ACA AGC ACT CCC ACT TCA
TC-3′, 3′-ATT CTG CCT CCT TCC ACC-5′; adipsin: 5′-CTG GCA
GTT CTG GTC CTC CT-3′, 3′-AGA ACC TGC ACC TTC CCG TC-5′;
leptin: 5′-TTA CAC AAT GCT GGC CTC CTT-3′, 3′-TTA CAC AAT
GCT GGC CTC CTT-5′; PPARγ: 5′-AGG AGC AGA GCA AAG AGG-
3′, 3′-AGG ACT CAG GGT GGT TCA-5′; COL II: 5′-TTC AGC TAT
GGA GAT GAC AAT C-3′, 3′-GAG TCA GTG AGA TCC TGA GA-5′;
chondroitin sulfate proteoglycan 4 (CSPG4): 5′-TTC CTT
CTT CGG TGA GAA CCA CCT-3′, 3′-TAA CGA GGT GTT GTC
ACA CGG ACA-5′; HLA-A: 5′-GGA GAA CGG GAA GGA GAC
G-3′, 3′-TAG AAG GGT CGG GTG GCA -5; HLA-DRA: 5′-GGC
GAG TTT ATG TTT GAC-3′,3′-AGG TTG ATA TGA GGC TAG
T-5′. PCR reaction products were separated by gel electro-
phoresis using a 1.5% agarose gel. Bands were visualized by UV
illumination of ethidium-bromide-stained gels and captured
using a ChemiImager 4400 Gel Imaging System (Alpha Innotech,
Shanghai, China). Band intensity was quantitatively analyzed
in triplicate by IMAGEJ software for each gene and was
normalized to corresponding GAPDH values.Flow cytometry
Cell-surface molecules were analyzed by Bechman–Coulter
Elite ESP Flow Cytometer (Beckman Coulter, Shanghai,
China). Briefly, cells were harvested and washed with PBS,
and then adjusted to a concentration of 2.0×106 cells/mL
with ice-cold PBS containing 3% bovine serum albumin (BSA).
Afterward, cells were incubated for 2 h at room temperature
with mouse anti-human CD29, CD34, CD45, CD73, CD90,
CD105, CD117, HLA-DR and HLA-ABC monoclonal antibodies
(1 μg antibody/106 cells). Antibodies with a matching isotype
were used to detect nonspecific fluorescence. After incuba-
tion, cells were washed three times by centrifugation at
400×g for 5 min and resuspended in ice-cold PBS. Fluorescein
isothiocyanate (FITC or PE)-conjugated secondary antibody
diluted in 3% BSA/PBS was applied for 30 min in the dark.
Table 1 Treatment groups of experimental animals.
Group Rat
number
Graft at left defect Graft at right defect
A 9 Construct with cells
isolated by TM
Construct with cells
isolated by DM
B 9 Construct with cells
isolated by TM
Blank scaffold
C 9 Construct with cells
isolated by DM
Blank scaffold
D 9 Blank scaffold Without any
scaffold
TM: the time-gradient attachment; DM: the direct attachment.
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resuspended in 0.2 mL 2% formalin, and analyzed for the
aforementioned human antigens by using Bechman–Coulter
Elite ESP Flow Cytometer. Cytofluorimetric data were pro-
cessed with WinMDI software (Joe Trotter, Scripps Research
Institute, La Jolla, CA).
Growth kinetics
Above analysis showed the cells isolated using the time-
gradient attachment method had characteristics of MSCs.
Therefore, we examined the growth kinetics of these cells in
comparison with those of cells isolated using the direct
attachment method. Growth curves of cells were generated
by seeding 2×104 cells per 24-well plate. The cell prolifer-
ation was evaluated by determining the double-stranded
DNA (dsDNA) content. At various interval times, the cells
were trypsinized using 0.25% trypsinase (Gibco-BRL) and
stored in ddH2O at −20 °C until the assay was performed. For
DNA content assay, the frozen cells were thawed at room
temperature and homogenized in 1 mL lysis buffer (50 mM
Tris/HCl, pH 7.6, 0.1% (v/v) Triton X-100). The lysate was
assayed for DNA content using a fluorescent dye Hoechst
33258. Briefly, the lysate was sonicated on ice for 30 s and
vortexed for 5–10 s. After centrifugation at 2000×g, the
supernatant was collected. Standards of calf thymus DNA
were prepared form 0 to 30 μg/mL. TNE buffer (10 mM Tris
base, 1 mM EDTA and 200 mM NaCl) was added to each well
of a 96-well plate at 50 μL/well. Standards and samples
were then added to each well at 50 μL/well. Afterward,
Hoechst 33258 dye solution (1 μg/mL) was added to each
well at 100 μL/well and allowed to incubate for 10 min in
dark at room temperature. Finally, the fluorescence was
read on Auto Microplate Reader (Infinite M200, Tecan) using
an excitation wavelength of 350 nm and an emission
wavelength of 450 nm. Cell number was determined by
correlating DNA with a known amount of cells. Samples were
run in triplicate and compared against calf thymus DNA
standards. The growth rate and the generation time were
calculated as described previously (Miki et al., 2005).
Culture of cells in PLGA scaffolds and transplantation
in calvaria of rats
Porous poly-lactic-co-glycolic acid (PLGA) was fabricated
into porous scaffolds (10×3 mm, 85% porosity, 280–450 μm
pore diameter) by a porogen-leaching technique with gelatin
particles as the porogen (Zhou et al., 2005). 1.8×106 cells
were seeded into each PLGA scaffold as described previously
(Zong et al., 2010). The PLGA-cell constructs were cultured
in 6-well plate with the complete medium for 24 h. Then,
the PLGA-cell constructs were transferred into the perfusion
culture system to culture for 4 d as described previously
(Yang et al., 2010). Afterward, the PLGA-cell constructs
were collected for the transplantation experiment.
All surgery for the transplantation experiment was
performed under a protocol approved by Zhejiang Scientific
and Technological Commission (ZSTC). Briefly, after general
anesthesia with 4% chloral hydrate, the skin and underlying
tissues of vertex were raised to expose the calvaria, and
then two full-thickness defects (5 mm in diameter) insymmetry to the sagittal suture were generated by a dental
bur. After the defects were implanted with PLGA-cell
constructs, a single layer of soft tissue was closed with
absorbable sutures, and then the skin incision was closed
with nylon sutures. After surgery, SD rats were kept in the
clean conditions with enough water and foods. 36 SD rats
used for the experiment were divided into four groups (see
Table 1).
To in vivo trace human cells in scaffolds grafted into rats,
we used the fluorescent carbocyanine CM-Dil to label cell
membranes. The method was an improvement on the
manufacturer's protocol (Ferrari et al., 2001). Briefly, at
24 h before transplantation, human cells in scaffold were
labeled with 4 μg/mL CM-Dil for about 2 h at 37 °C, and then
the scaffold was washed with PBS for three times and
continuously cultured in the perfusion culture system until
transplantation. Cell tracing was performed at 10 weeks
after transplantation. Tissue samples from defect areas
were harvested from 4 groups (3 samples per group) and
decalcified in Decalcifying Fluid (Zhongshan, Beijing, China)
for 4 days at room temperature, and then washed in running
water for about 2 h. The 7 μm frozen section of sample was
prepared and then counterstained by DAPI for 5 min. The
result was observed using a Confocal Laser Scanning
Microscope (LSM-510, Carl Zeiss, Germany).
After 20 weeks, other rats were sacrificed by cervical
dislocation or euthanasia with an overdose of chloral
hydrate, and their calvarias with constructs were harvested.
Tissue samples were fixed, decalcified and embedded in
paraffin. 5 μm sections of the sample were prepared and
stained with hematoxylin and eosin (H&E) and Modified
Masson Trichrome as previously described (Zong et al.,
2010). Semi-quantitative image analysis (Ahmad and Ahmed,
2004; Zsarnovszky et al., 2005) was used to estimate the new
forming bone and calculate the percentage of newly formed
bone within the defect using the computerized image
analysis software Image-Pro Plus (IPP) 6.0. Immunohisto-
chemical analysis of human osteocalcin (hOCN) was per-
formed using the Histostain-Plus IHC Kit (MR Biotech,
Shanghai, China) according to the manufacturer's instruc-
tions. Briefly, sections of samples were prepared as
described above, and then deparaffinized, rehydrated and
incubated in 3% hydrogen peroxide in methanol for 10 min to
inactivate the endogenous peroxidase. After three times
washing with PBS, the sections were digested with Trypsin
Diluent (Zhongshan, Beijing, China) for 15 min to unmask
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After that, the sections were incubated with 10% goat serum
for 20 min to block non-specific binding, followed by
incubation with the primary antibody, i.e., rabbit polyclonal
antibody against hOCN (Abcam, Hangzhou, China) overnight
at 4 °C. Afterwards, the sections were washed three times
with PBS and incubated with biotinylated IgG against rabbit
for 15 min, and then exposed to horseradish peroxidase
(HRP) labeled streptavidin for 15 min. After washing three
times with PBS, the antibody complex was visualized by
addition of a buffered diaminobenzidine (DAB) solution.
Then, the sections were counterstained in hematoxylin for
5 min and mounted with neutral gum. The sections treated
only with the second antibody (without primary antibody
treatment) were used as a negative control. To evaluate the
protein content of human OCN expressed by implanted cells
in the graft area, we used IPP as the method of semi-
quantitative image analysis on immunohistochemical section
image to measure the Integrated Optical Density (IOD)
(Cybernetics, 2002). Inflammatory cells were identified by
CD11b+ expression as described previously (Solovjov et al.,
2005) with a little modification. Briefly, the section was
fixed with paraformaldehyde, and then blocking with 5% BSA
for 1 h at 25 °C was performed. The section was incubated
with rat antibody against CD11b (1/100) (Abcam, Shanghai,
China) for 12 h at 4 °C in PBS. A Cy3-conjugated donkey
polyclonal to rat IgG was used at dilution at 1/500 as
secondary antibody.
Statistical analysis
All experiments were repeated for at least three times and the
representative data were presented as means±standard
deviation where indicated. Statistical analysis was performed
using factorial analysis of variance (two-way ANOVA). A
probability value of less than 0.05 was statistically considered
significant: *(Pb0.05).
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